These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 1426419)
21. Interleukin-2-secreting mouse fibroblasts transfected with genomic DNA from murine neoplasms induce tumor-specific immune responses that prolong the lives of tumor-bearing mice. Sun T; Kim TS; Waltz MR; Cohen EP Cancer Gene Ther; 1995 Sep; 2(3):183-90. PubMed ID: 8528961 [TBL] [Abstract][Full Text] [Related]
22. Vaccination with IL-2-secreting tumor cells stimulates the generation of IL-2-responsive T cells and prevents the development of unresponsiveness. Zier KS; Salvadori S; Cronin KC; Gansbacher B Cancer Gene Ther; 1994 Mar; 1(1):43-50. PubMed ID: 7621237 [TBL] [Abstract][Full Text] [Related]
23. Purification of L-selectin(low) cells promotes the generation of highly potent CD4 antitumor effector T lymphocytes. Kagamu H; Shu S J Immunol; 1998 Apr; 160(7):3444-52. PubMed ID: 9531305 [TBL] [Abstract][Full Text] [Related]
24. Multiple and heterogeneous patterns of cytokine production in 18 leukemia and in vitro transformed mature T cell lines reflect the individuality of human leukemias. Dao T; Holán V; Minowada J Int J Hematol; 1993 Apr; 57(2):139-46. PubMed ID: 8494992 [TBL] [Abstract][Full Text] [Related]
25. Expression of proinflammatory and proangiogenic cytokines in patients with head and neck cancer. Chen Z; Malhotra PS; Thomas GR; Ondrey FG; Duffey DC; Smith CW; Enamorado I; Yeh NT; Kroog GS; Rudy S; McCullagh L; Mousa S; Quezado M; Herscher LL; Van Waes C Clin Cancer Res; 1999 Jun; 5(6):1369-79. PubMed ID: 10389921 [TBL] [Abstract][Full Text] [Related]
26. Interferon-gamma: biologic functions and HCV therapy (type I/II) (1 of 2 parts). Gattoni A; Parlato A; Vangieri B; Bresciani M; Derna R Clin Ter; 2006; 157(4):377-86. PubMed ID: 17051976 [TBL] [Abstract][Full Text] [Related]
27. Murine endothelioma cell lines transformed by polyoma middle T oncogene as target for and producers of cytokines. Bussolino F; De Rossi M; Sica A; Colotta F; Wang JM; Bocchietto E; Padura IM; Bosia A; DeJana E; Mantovani A J Immunol; 1991 Oct; 147(7):2122-9. PubMed ID: 1918946 [TBL] [Abstract][Full Text] [Related]
28. Depressed IL-1 production by chronic GVHD dermal fibroblasts. Mekori YA; Huleihel M; Baram D; Apte RN Eur Cytokine Netw; 1990; 1(2):77-83. PubMed ID: 2102813 [TBL] [Abstract][Full Text] [Related]
29. Cancer immunotherapy of established tumors with IL-12. Effective delivery by genetically engineered fibroblasts. Zitvogel L; Tahara H; Robbins PD; Storkus WJ; Clarke MR; Nalesnik MA; Lotze MT J Immunol; 1995 Aug; 155(3):1393-403. PubMed ID: 7636204 [TBL] [Abstract][Full Text] [Related]
30. Inhibition of cytokine activation processes in vitro by tenidap, a novel anti-inflammatory agent. McNiff PA; Laliberte RE; Svensson L; Pazoles CJ; Gabel CA Cytokine; 1995 Feb; 7(2):196-208. PubMed ID: 7780040 [TBL] [Abstract][Full Text] [Related]
31. Cellular basis of immunologic interactions in adoptive T cell therapy of established metastases from a syngeneic murine sarcoma. Ward BA; Shu S; Chou T; Perry-Lalley D; Chang AE J Immunol; 1988 Aug; 141(3):1047-53. PubMed ID: 3260908 [TBL] [Abstract][Full Text] [Related]
32. The syngeneic T-T lymphocyte reaction (STTLR). II. Induction of primary T anti-T cell cytotoxic responses in vitro in T cell cultures stimulated with syngeneic self-reactive T cells. Suzuki H; Quintáns J J Mol Cell Immunol; 1986; 2(6):345-57. PubMed ID: 3509919 [TBL] [Abstract][Full Text] [Related]
33. Successful adoptive immunotherapy of murine poorly immunogenic tumor with specific effector cells generated from gene-modified tumor-primed lymph node cells. Tanaka H; Yoshizawa H; Yamaguchi Y; Ito K; Kagamu H; Suzuki E; Gejyo F; Hamada H; Arakawa M J Immunol; 1999 Mar; 162(6):3574-82. PubMed ID: 10092816 [TBL] [Abstract][Full Text] [Related]
34. Tumor-induced regulation of suppressor macrophage nitric oxide and TNF-alpha production. Role of tumor-derived IL-10, TGF-beta, and prostaglandin E2. Alleva DG; Burger CJ; Elgert KD J Immunol; 1994 Aug; 153(4):1674-86. PubMed ID: 8046239 [TBL] [Abstract][Full Text] [Related]
35. Expression of pro-inflammatory markers by human dermal fibroblasts in a three-dimensional culture model is mediated by an autocrine interleukin-1 loop. Kessler-Becker D; Krieg T; Eckes B Biochem J; 2004 Apr; 379(Pt 2):351-8. PubMed ID: 14686880 [TBL] [Abstract][Full Text] [Related]
36. Transcription of genes encoding granulocyte-macrophage colony-stimulating factor, interleukin 3, and interleukin 6 receptors and lack of proliferative response to exogenous cytokines in nonhematopoietic human malignant cell lines. Guillaume T; Sekhavat M; Rubinstein DB; Hamdan O; Symann ML Cancer Res; 1993 Jul; 53(13):3139-44. PubMed ID: 8319222 [TBL] [Abstract][Full Text] [Related]
37. Tumor-induced dysfunction in interleukin-2 production and interleukin-2 receptor signaling: a mechanism of immune escape. Rayman P; Uzzo RG; Kolenko V; Bloom T; Cathcart MK; Molto L; Novick AC; Bukowski RM; Hamilton T; Finke JH Cancer J Sci Am; 2000 Feb; 6 Suppl 1():S81-7. PubMed ID: 10685665 [TBL] [Abstract][Full Text] [Related]
38. Expression of the tumor necrosis factor gene in tumor cells correlates with reduced tumorigenicity and reduced invasiveness in vivo. Vanhaesebroeck B; Mareel M; Van Roy F; Grooten J; Fiers W Cancer Res; 1991 Apr; 51(8):2229-38. PubMed ID: 2009541 [TBL] [Abstract][Full Text] [Related]